(Q48785460)

15 February 2018

review article

1 reference

title

Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. (English)

1 reference

15 February 2018

author name string

B Jarvis

series ordinal

1

1 reference

15 February 2018

A J Coukell

series ordinal

2

1 reference

15 February 2018

publication date

1 October 1998

1 reference

15 February 2018

published in

Drugs

1 reference

15 February 2018

volume

56

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

691-707

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.2165/00003495-199856040-00016

exact match

0 references

cites work

Dercum's disease (adiposis dolorosa). Treatment of the severe pain with intravenous lidocaine

1 reference

12 December 2020

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

12 December 2020

Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study

1 reference

12 December 2020

Mexiletine for painful alcoholic neuropathy

1 reference

12 December 2020

Pain due to peripheral nerve damage: an hypothesis

1 reference

12 December 2020

The natural history of painful diabetic neuropathy--a 4-year study

1 reference

12 December 2020

Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice

1 reference

12 December 2020

Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study

1 reference

12 December 2020

Oral mexiletine-theophylline interaction

1 reference

12 December 2020

Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers

1 reference

12 December 2020

Effect of mexiletine on spinal cord injury dysesthetic pain.

1 reference

12 December 2020

Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer

1 reference

12 December 2020

Mexiletine and caffeine elimination

1 reference

12 December 2020

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

12 December 2020

Increase of mexiletine plasma levels due to delayed hepatic metabolism in patients with chronic liver disease

1 reference

12 December 2020

Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction

1 reference

12 December 2020

The Use of Oral Mexiletine for the Treatment of Pain after Peripheral Nerve Injury

1 reference

12 December 2020

Peripheral diabetic neuropathy: current concepts in treatment

1 reference

12 December 2020

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales

1 reference

12 December 2020

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine

1 reference

12 December 2020

Mexiletine disposition: individual variation in response to urine acidification and alkalinisation

1 reference

12 December 2020

Systemic lidocaine therapy for poststroke pain.

1 reference

12 December 2020

What causes neuropathic pain?

1 reference

12 December 2020

Causes of neuropathic pain

1 reference

12 December 2020

[Mexiletine in terminal renal failure and various dialysis procedures]

1 reference

12 December 2020

Effect of cigarette smoking on mexiletine kinetics

1 reference

12 December 2020

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

12 December 2020

Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man.

1 reference

12 December 2020

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

1 reference

12 December 2020

Clinical versus statistical significance in the assessment of pain relief

1 reference

12 December 2020

Comparable dose-dependent inhibition of AP-7 sensitive strychnine-induced allodynia and paw pinch-induced nociception by mexiletine in the rat.

1 reference

12 December 2020

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

1 reference

12 December 2020

Effect of rifampicin treatment on the kinetics of mexiletine

1 reference

12 December 2020

Pharmacokinetics and nondialyzability of mexiletine in renal failure

1 reference

12 December 2020

Mexiletine effects on theophylline disposition.

1 reference

12 December 2020

A comparison of the action of mexiletine and morphine in rodent models of acute and chronic pain

1 reference

12 December 2020

Cirrhosis of the liver markedly impairs the elimination of mexiletine

1 reference

12 December 2020

Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans

1 reference

12 December 2020

Effects of age on the pharmacokinetics of mexiletine.

1 reference

12 December 2020

The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation

1 reference

12 December 2020

Mexiletine-theophylline interaction

1 reference

12 December 2020

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

1 reference

12 December 2020

The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas

1 reference

12 December 2020

Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration

1 reference

12 December 2020

Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline

1 reference

12 December 2020

The minimum clinically important difference in physician-assigned visual analog pain scores

1 reference

12 December 2020

Successful treatment for phantom pain

1 reference

12 December 2020

Mexiletine kinetics in healthy subjects taking cimetidine

1 reference

12 December 2020

Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management.

1 reference

12 December 2020

The evolving science of pharmacogenetics: clinical and ethnic perspectives.

1 reference

12 December 2020

Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence

1 reference

12 December 2020

Painful polyneuropathy

1 reference

12 December 2020

Diabetic neuropathy in the elderly

1 reference

12 December 2020

Painful polyneuropathy: diagnosis, pathophysiology, and management

1 reference

12 December 2020

Lack of a kinetic interaction between fluconazole and mexiletine

1 reference

12 December 2020

The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization

1 reference

12 December 2020

Enhanced metabolism of mexiletine after phenytoin administration

1 reference

12 December 2020

Mexiletine in the Symptomatic Treatment of Diabetic Peripheral Neuropathy

1 reference

12 December 2020

1 reference

12 December 2020

Dose independent pharmacokinetics of mexiletine in healthy volunteers

1 reference

12 December 2020

A systematic review of antidepressants in neuropathic pain

1 reference

12 December 2020

Chronic pain: from theory to practical management

1 reference

12 December 2020

Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias

1 reference

12 December 2020

Mexiletine for chronic pain

1 reference

12 December 2020

Mexiletine in the treatment of diabetic neuropathy

1 reference

12 December 2020

Involvement of CYP1A2 in mexiletine metabolism

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

[Mexiletine in treatment of painful diabetic neuropathy]

1 reference

12 December 2020

The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy

1 reference

12 December 2020

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

1 reference

12 December 2020

Pharmacokinetics of mexiletine in renal insufficiency

1 reference

12 December 2020

Stereoselective metabolism of rac-mexiletine by the fungus Cunninghamella echinulata yields the major human metabolites hydroxymethylmexiletine and p-hydroxymexiletine

1 reference

12 December 2020

How do drugs relieve neurogenic pain?

1 reference

12 December 2020

Relief of severe diabetic truncal pain with mexiletine

1 reference

12 December 2020

Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers

1 reference

12 December 2020

Stereoselective disposition of mexiletine in man

1 reference

12 December 2020

Systemic mexiletine relieves chronic allodynialike symptoms in rats with ischemic spinal cord injury

1 reference

12 December 2020

Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.

1 reference

12 December 2020

Treatment of myotonia with antiarrhythmic drugs

1 reference

12 December 2020

A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee

1 reference

12 December 2020

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

The visual analogue pain intensity scale: what is moderate pain in millimetres?

1 reference

12 December 2020

Antinociceptive effect of mexiletine in diabetic mice

1 reference

12 December 2020

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effects of mexiletine on formalin-induced nociceptive responses in mice

1 reference

12 December 2020

Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine

1 reference

12 December 2020

A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.

1 reference

12 December 2020

1 reference

12 December 2020

Interaction between Theophylline and Mexiletine

1 reference

12 December 2020

Nerve growth factor and diabetic neuropathy

1 reference

12 December 2020

Two cases of multiple sclerosis with painful tonic seizures and dysesthesia ameliorated by the administration of mexiletine

1 reference

12 December 2020

Mexiletine for thalamic pain syndrome.

1 reference

12 December 2020

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

12 December 2020

Population pharmacokinetic parameters in patients treated with oral mexiletine

1 reference

12 December 2020

Update: clinically significant cytochrome P-450 drug interactions

1 reference

12 December 2020

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group

1 reference

12 December 2020

Influence of mexiletine on caffeine elimination

1 reference

12 December 2020

Pharmacotherapy of neuropathic pain

1 reference

12 December 2020

Use of differential normal pulse voltammetry for the measurement of locus coeruleus catecholaminergic metabolism in an acute anaesthetized rodent model of allodynia: effect of mexiletine.

1 reference

12 December 2020

Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias

1 reference

12 December 2020

10.2165/00003495-199856040-00016

Identifiers

DOI

1 reference

15 February 2018

Dimensions Publication ID

1016913643

0 references

1 reference

15 February 2018